This measure describes the change in functional communication status subsequent to speech-language pathology treatment related to spoken language comprehension.
This measure describes the change in functional communication status subsequent to speech-language pathology treatment related to spoken language expression.
Number of stroke patients who make progress as defined by an increase of one or more levels on the Writing Functional Communication Measure (FCM).
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients who have attention deficits.
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients with reading disorders.
This measure describes the change in functional communication status subsequent to speech-language pathology treatment of patients who exhibit difficuty in swallowing.
Percentage of visits for patients aged 18 years and older with documentation of a current functional outcome assessment using a standardized functional outcome assessment tool on the date of the encounter AND documentation of a care plan based on identified functional outcome deficiencies on the date of the identified deficiencies
Percentage of patients aged 18 and older with a diagnosis of gout treated with urate-lowering therapy (ULT) for at least 12 months, whose most recent serum urate result is less than 6.8 mg/dL.
Percentage of patients aged 18 and older with a diagnosis of gout and either tophus/tophi or at least two gout flares (attacks) in the past year who have a serum urate level > 6.0 mg/dL, who are prescribed urate lowering therapy (ULT)
The percentage of patients with COPD who are found to improve their health-related quality of life score (HRQoL) as measured by a valid and reliable instrument after participating in pulmonary rehabilitation
(PR).